NetworkNewsBreaks

FridayApr 08, 2022 1:48 pm

NetworkNewsBreaks – Why Correlate Infrastructure Partners Inc. (CIPI) Is ‘One to Watch’

Correlate Infrastructure Partners (OTCQB: CIPI) is leading the charge toward creating an industry-leading energy solution and financing platform for the commercial and industrial sector, with its transparent, cutting-edge model changing value delivery for both facility owners and proven solution providers seeking scale. Through its two subsidiaries, Correlate and Solar Site Design, the company offers a complete suite of proprietary clean energy assessment and fulfillment solutions while simultaneously eying the tremendous market opportunity in reducing site-specific energy consumption and deploying clean energy generation and energy efficiency solutions at scale. “The opportunity exists to remove friction between today’s legacy finance process and…

Continue Reading

FridayApr 08, 2022 1:42 pm

NetworkNewsBreaks – Guardforce AI Co. Limited (NASDAQ: GFAI) Announces Pricing of $10.0M Registered Direct Offering

Guardforce AI (NASDAQ: GFAI, GFAIW), an integrated security solutions provider, has announced its entry into a securities purchase agreement with certain institutional investors to purchase approximately $10.0 million worth of its ordinary shares in a registered direct offering. Under the terms, the company has agreed to sell approximately 8.7 million of its ordinary shares, each at a price of $1.15. The company expects to secure approximately $10.0 million in gross proceeds from the registered direct offering, which is anticipated to close on or about April 8, 2022. EF Hutton, division of Benchmark Investments LLC, is acting as exclusive placement agent…

Continue Reading

FridayApr 08, 2022 1:31 pm

NetworkNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Working to Capitalize on Psychedelics Therapeutics Market’s Growth

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) is a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders. A recent article discusses the company’s efforts to lead the charge toward developing novel psychedelic and non-psychedelic molecules for medical use. “Its research and development efforts have focused on compounds that can enable safer and more effective treatments for patients dealing with mental health and addiction disorders with unmet needs,” the article reads. “Mydecine, through its research, has positioned itself to capitalize on the opportunities in the industry, particularly with regards to psychedelic medicine for the treatment…

Continue Reading

FridayApr 08, 2022 12:17 pm

NetworkNewsBreaks – LQwD FinTech Corp.’s (TSX.V: LQWD) (OTCQB: LQWDF) PaaS Platform Facilitating Instant, Secure, Inexpensive Payments

LQwD FinTech (TSX.V: LQWD) (OTCQB: LQWDF), a company focused on developing institution-grade payment infrastructure, liquidity and solutions for the Lightning Network, introduced its platform-as-a-service (“PaaS”) in November 2021. The platform offers users the ability to make payments instantly, securely and inexpensively while leveraging the Lightning Network. “Since that time, LQwD has also invested in the Lightning Network, with nine active public nodes. The active nodes include France, England, Singapore, Sweden, Italy, Indonesia, Germany, Ireland, and the U.S. Collectively, the public nodes have a value of 10.21604901 BTC ($429,153.33) and 183 active channels,” a recent article reads. This comes amid growth…

Continue Reading

FridayApr 08, 2022 11:40 am

NetworkNewsBreaks – Cybin Inc. (NYSE American: CYBN) (NEO: CYBN) Further Strengthens Long-Term IP Position of Psychedelic-Based Programs

Cybin (NYSE American: CYBN) (NEO: CYBN), a biopharmaceutical company focused on progressing “Psychedelics to Therapeutics(TM),” has announced that the World Intellectual Property Organization (“WIPO”) published an international patent application covering a range of inhalation delivery methods across multiple psychedelic molecules (Patent Cooperation Treaty (‘PCT’) patent application no.PCT/EP2021/077057). This further strengthens the company’s long-term intellectual property (“IP”) position of psychedelic-based programs. “The publication of this PCT patent application demonstrates our continued commitment to discovering and developing new psychedelic-based treatment options, in addition to identifying and combining potentially improved and well-controlled delivery systems with these clinical candidates,” said Cybin CEO Doug Drysdale.…

Continue Reading

ThursdayApr 07, 2022 2:36 pm

NetworkNewsBreaks – Nowigence Inc.’s Pluaris Helping Users Make Sense of Massive Amounts of Textual Data

Nowigence has introduced Pluaris, an all-in-one, easy-to-use personal knowledge management platform designed to assist users with automated reading and analysis of textual data. “The system reads and analyzes articles, documents and other textual data, enabling readers to learn more in less time, uncover hidden insights, and stay on top of the information they need to know. Pluaris helps individuals, teams and entire enterprises make sense of massive amounts of textual data, converting them into bite-size nuggets of intelligence in a short span of time,” a recent article explains. “Once Pluaris has done its job, users simply scan their customized newsfeeds…

Continue Reading

ThursdayApr 07, 2022 2:23 pm

NetworkNewsBreaks – Why Silo Pharma Inc. (SILO) Is ‘One to Watch’

Silo Pharma (OTCQB: SILO) is committed to developing innovative solutions to address various underserved conditions such as post-traumatic stress disorder (“PTSD”), fibromyalgia, Alzheimer’s, Parkinson’s, and other rare neurological disorders as part of its focus on merging traditional therapeutics with psychedelic research. “Silo works to identify and partner with leading medical universities, providing the needed financial resources to develop safe therapeutic treatments while moving cutting-edge research through the clinical stage and into commercialization. The company is well-capitalized with access to additional funds as opportunities present themselves,” a recent article reads. Silo Pharma is involved in a sponsored study with Maastricht University…

Continue Reading

ThursdayApr 07, 2022 2:08 pm

NetworkNewsBreaks – Lift&Co. Expo Announce IBN, CannabisNewsWire as Media Partner

Lift&Co. has selected InvestorBrandNetwork (“IBN”) as a media partner for its upcoming Lift&Co. Expo, held on May 12–15, 2022, in Toronto. Recognized as one of Canada’s top cannabis conference and trade shows, Lift&Co. Expo is a can’t-miss event for cannabis industry professionals, investors, consumers and media. According to the announcement, IBN, along with its CannabisNewsWire brand, will partner with Lift&Co. to provide comprehensive coverage of the event. Organizers of this year’s expo anticipate more than 10,000 attendees, with more than 250 exhibitors displaying the latest products, services and industry innovations available. The event agenda also features insightful addresses, presentations and…

Continue Reading

ThursdayApr 07, 2022 1:32 pm

NetworkNewsBreaks – FuelPositive Corporation (TSX.V: NHHH) (OTCQB: NHHHF) Adds Talent to Capitalize on Broad Range of Emerging Agricultural Opportunities

FuelPositive (TSX.V: NHHH) (OTCQB: NHHHF) recently announced that experienced global agricultural product operations leader Derek Boudreau joined the company as a strategic advisor, responsible for agricultural implementation. Boudreau joins FuelPositive after more than 27 years with John Deere Company. His addition to the team highlights the company’s build-up toward commercialization of its intellectual property (“IP”), with FuelPositive expecting to begin rolling out the prototype of its modular green ammonia production systems in late summer 2022. A recent article quotes FuelPositive CEO and Board Chair Ian Clifford as saying: “[Boudreau’s] vast experience working in sales, management, manufacturing, and distribution with agricultural…

Continue Reading

ThursdayApr 07, 2022 12:55 pm

NetworkNewsBreaks – Kronos Advanced Technologies Inc. (KNOS) Developing the Most Effective Clean-Air Solution on the Market

Kronos Advanced Technologies (OTC: KNOS), a revenue-generating product development and production company that has significantly changed the way air is moved, filtered and disinfected, has developed one of the most effective air purifiers available today. With reports showing that indoor air pollution is a risk factor for several of the world’s leading causes of death, including heart disease, pneumonia, stroke, diabetes, lung cancer, and viruses, air purifiers can help remove or reduce pollutants by using a combination of chemicals, physical filters and devices. A recent article reads: “Kronos is making its presence felt in the growing sector with its proprietary,…

Continue Reading